A detailed history of Resources Investment Advisors, Llc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Resources Investment Advisors, Llc. holds 10,120 shares of HALO stock, worth $483,837. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,120
Previous 10,663 5.09%
Holding current value
$483,837
Previous $558,000 3.58%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$51.3 - $64.42 $27,855 - $34,980
-543 Reduced 5.09%
10,120 $578,000
Q2 2024

Aug 02, 2024

BUY
$37.81 - $52.4 $196,044 - $271,694
5,185 Added 94.65%
10,663 $558,000
Q1 2024

May 10, 2024

BUY
$33.68 - $41.95 $184,499 - $229,802
5,478 New
5,478 $222,000
Q1 2023

May 10, 2023

SELL
$32.86 - $55.7 $16,101 - $27,293
-490 Reduced 7.56%
5,992 $228,000
Q4 2022

Feb 02, 2023

BUY
$40.06 - $59.44 $640 - $951
16 Added 0.25%
6,482 $368,000
Q3 2022

Nov 08, 2022

BUY
$38.53 - $51.78 $27,009 - $36,297
701 Added 12.16%
6,466 $256,000
Q2 2022

Aug 08, 2022

BUY
$37.35 - $48.3 $560 - $724
15 Added 0.26%
5,765 $254,000
Q4 2021

Feb 23, 2022

BUY
$31.82 - $40.75 $23,865 - $30,562
750 Added 15.0%
5,750 $231,000
Q3 2021

Nov 05, 2021

SELL
$38.47 - $46.42 $2,115 - $2,553
-55 Reduced 1.09%
5,000 $203,000
Q2 2021

Aug 09, 2021

SELL
$38.84 - $51.31 $49,171 - $64,958
-1,266 Reduced 20.03%
5,055 $229,000
Q1 2021

May 10, 2021

BUY
$39.51 - $51.45 $36,902 - $48,054
934 Added 17.34%
6,321 $263,000
Q4 2020

Feb 08, 2021

BUY
$25.81 - $43.62 $139,038 - $234,980
5,387 New
5,387 $230,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.66B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Resources Investment Advisors, Llc. Portfolio

Follow Resources Investment Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Investment Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Resources Investment Advisors, Llc. with notifications on news.